Piperidine-1-carboximidamide hemisulfate

Catalog No. :
ACHPJB905
CAS No. :
17238-53-8
Molecular Formula :
C12H28N6O4S
Molecular Weight :
352.46

IUPAC Name:piperidine-1-carboximidamide hemisulfate

Piperidine-1-carboximidamide hemisulfate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$84.00Login to see priceIn stockInquiry
5g98%$302.00Login to see priceIn stockInquiry
10g98%$538.00Login to see priceIn stockInquiry
25g98%$1136.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePiperidine-1-carboximidamide hemisulfate
IUPAC Namepiperidine-1-carboximidamide hemisulfate
MDL No.MFCD01748702
Molecular FormulaC12H28N6O4S
Molecular Weight352.46
SMILESO=S(O)(O)=O.N=C(N)N1CCCCC1.N=C(N)N2CCCCC2
InChI KeyXEMFKRVIVCQOPE-UHFFFAOYSA-N
SynonymBis(piperidine-1-carboximidamide) hemisulfate;PIPERIDINE-1-CARBOXAMIDINE HEMISULFATE;piperidine-1-carboximidamide sulfate;Bis(piperidine-1-carboximidamide) sulfuric acid;piperidine-1-carboxamidine hemisulfate 2(;bis(piperidine-1-carboximidamide)
CAS No.17238-53-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACHPJB905 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACHPJB905 route product structure diagram
    ACHPJB90517238-53-8 In Stock
Inquiry

2. ACHPJB905 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACHPJB905 route product structure diagram
    ACHPJB90517238-53-8 In Stock
Inquiry

Comments (0)